Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
19%
OVERLAP
BY WEIGHT
8
# OF OVERLAPPING
HOLDINGS
XLV
59
HOLDINGS
14%
ALSO IN CANC
CANC
53
HOLDINGS
15%
ALSO IN XLV
SECTOR DRIFT (XLV minus CANC)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XLV |
Weight in CANC |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 15.2% | 4.4% | 4.4% |
|
MERCK & CO. INC. | 5.3% | 3.4% | 3.4% |
|
ABBVIE INC | 7.1% | 2.7% | 2.7% |
|
JOHNSON & JOHNSON | 10.4% | 2.6% | 2.6% |
|
BRISTOL-MYERS SQUIBB CO | 2.2% | 3.3% | 2.2% |
XLV Overweight Relative to CANC
|
ELI LILLY & CO | 10.8% |
|
JOHNSON & JOHNSON | 7.8% |
|
UNITEDHEALTH GROUP INC | 6.8% |
|
ABBVIE INC | 4.4% |
|
THERMO FISHER SCIENTIFIC INC | 3.1% |
|
INTUITIVE SURGICAL INC | 2.8% |
|
ABBOTT LABORATORIES | 2.8% |
|
PFIZER INC | 2.7% |
|
CVS CAREMARK CORP | 2.3% |
|
VERTEX PHARMACEUTICALS INC | 2.1% |
XLV Underweight Relative to CANC
|
REVOLUTION MEDICINES, INC. | -7.2% |
 |
ROCHE HOLDINGS LTD-SPONS ADR | -4.1% |
|
NOVARTIS AG | -4.1% |
|
COGENT BIOSCIENCES INC | -3.8% |
|
IMMUNOME, INC. | -3.8% |
|
CELCUITY INC. | -3.7% |
 |
ASTRAZENECA PLC | -3.5% |
|
NUVALENT, INC. CLASS A | -3.1% |
|
LEGEND BIOTECH CORPORATION SPONSORED | -3.0% |
|
EXELIXIS INC | -2.8% |